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Accepted 2 August 2012AbstractObjective: This study aims at presenting prenatal diagnosis of mosaic trisomy 2 and reviewing the literature.
Materials, Methods, and Results: A 32-year-old woman underwent amniocentesis at 21 weeks of gestation because of abnormal maternal serum
biochemistry. Amniocentesis revealed a karyotype of 47,XY,þ2[1]/46,XY[21] in in situ cultures. The single colony with trisomy 2 had two
metaphase cells, and both had the karyotype of 47,XY,þ2. Repeated amniocentesis was performed at 23 weeks of gestation. Interphase fluo-
rescence in situ hybridization (FISH) analysis on uncultured amniocytes using a 2q11.1-specific probe RP11-468G5 (spectrum green) showed
three green signals in 11 of 47 uncultured amniocytes, indicating 23.4% mosaicism for trisomy 2. The cultured amniocytes had a karyotype of
46,XY[20 colonies]. Polymorphic DNA marker analysis excluded uniparental disomy 2. The woman underwent the third amniocentesis at 25
weeks of gestation. Interphase FISH analysis on uncultured amniocytes revealed 9.4% (5/53 cells) mosaicism for trisomy 2. The cultured
amniocytes had a karyotype of 46,XY[30 colonies]. Prenatal ultrasound was normal. The parents decided to continue the pregnancy to term, and
a 3316-g baby was delivered with no phenotypic abnormalities. Cord blood had a karyotype of 46,XY[40 cells]. Interphase FISH analysis on
uncultured urinary cells revealed 8.2% (4/49 cells) mosaicism for trisomy 2. The neonate was normal in growth and psychomotor development at
6 months of age.
Conclusion: Prenatal diagnosis of a single colony with two or more cells with trisomy 2 at amniocentesis should alert a clinically significant
aneuploidy, and interphase FISH on uncultured amniocytes is useful for rapid confirmation of low-level trisomy 2 mosaicism at amniocentesis.
The abnormal cell line of trisomy 2 may disappear after long-term amniocyte cultures.
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Complete trisomy 2 or nonmosaic trisomy 2 is lethal and
has been found in 1% to 5e6% of first-trimester spontaneous
abortions [1,2]. The prevalence of mosaic trisomy 2 in cho-
rionic villus sampling has been estimated to be one in 2000
samplings [3e6]. Prenatal diagnosis of mosaic trisomy 2 by
amniocentesis is uncommon. Sago et al [7] found one case of
true cytogenetic trisomy 2 mosaicism among 58,000 amnio-
centeses. Mosaic trisomy 2 has phenotypic and cytogenetic
variability (Table 1). Characteristic phenotypic features in
abnormal livebirths with mosaic trisomy 2 include intrauterine
growth restriction (IUGR), microcephaly, midface hypoplasia,
hypertelorism, cleft lip, cleft palate, widely spaced nipples,
radioulnar hypoplasia, scoliosis, growth and motor delay,
inguinal hernia, congenital diaphragmatic hernia, rocker-
bottom feet, cardiac defects, neural tube defects, intestinal
malrotation, portal fibrosis, bronchopulmonary dysplasia,
hypomelanosis of Ito, caudal dysgenesis, Hirschsprung
disease, and micro-anophthalmia [7,9e12,15,19e22]. Herein,
we present our experience of prenatal diagnosis of mosaic
trisomy 2 by amniocentesis and a review of the literature.
Materials, methods, and results
A 32-year-old, primigravid woman underwent amniocen-
tesis at 21 weeks of gestation because of an abnormal result of
second-trimester maternal serum screening. The maternal
serum biochemistry at 15 weeks of gestation revealed a Down
syndrome risk of 1/149 calculated from the levels of 0.56,
0.94, 1.09, and 1.76 multiples of the median (MoM) for a-
fetoprotein (AFP), unconjugated estriol (uE3), total b-human
chorionic gonadotrophin (b-hCG), and inhibin-A, respectively.
Cytogenetic analysis of cultured amniocytes revealed
a karyotype of 47,XY,þ2[1]/46,XY[21]. Of 22 colonies of
cultured amniocytes, one colony had the karyotype of
47,XY,þ2, whereas the other 21 colonies had the karyotype
of 46,XY (Fig. 1). The single colony with trisomy 2 had two
metaphase cells, and each cell had a karyotype of 47,XY,þ2.
The parental karyotypes were normal, and prenatal ultrasound
findings were unremarkable. Repeated amniocentesis was
performed at 23 weeks of gestation. Array comparative
genomic hybridization (aCGH), interphase fluorescence in situ
hybridization (FISH), and quantitative fluorescent polymerase
chain reaction (QF-PCR) were applied on uncultured amnio-
cytes, and conventional cytogenetic analysis was applied on
cultured amniocytes. The aCGH analysis on uncultured
amniocytes revealed no genomic imbalance in chromosome 2.
Interphase FISH analysis on uncultured amniocytes using
a 2q11.1-specific probe of RP11-468G5 (spectrum green)
showed three green signals in 23.4% (11/47 cells) and two
green signals in 76.6% (36/47 cells) of uncultured amniocytes
(Fig. 2). QF-PCR analysis on uncultured amniocytes using
chromosome 2-specific microsatellite markers revealed a 1:1
biparental diallelic pattern for chromosome 2 and thus
excluded uniparental disomy (UPD) 2 (Fig. 3). Cytogenetic
analysis of cultured amniocytes revealed a karyotype of 46,XYin 20 cultured colonies. The woman underwent the third
amniocentesis at 25 weeks of gestation. Interphase FISH
analysis on uncultured amniocytes using the RP11-468G5
(2q11.1; spectrum green) probe showed three green signals
in 9.4% (5/53 cells) and two green signals in 91.6% (48/53
cells) of uncultured amniocytes (Fig. 4). Cytogenetic analysis
of cultured amniocytes revealed a karyotype of 46,XY in 30
cultured colonies. The parents decided to continue the preg-
nancy. A healthy 3316-g male baby was delivered at 40 weeks
of gestation with no phenotypic abnormalities. Cytogenetic
analysis of cord blood revealed a karyotype of 46,XY in 40
cultured lymphocytes. Interphase FISH analysis on uncultured
urinary cells using the RP11-468G5 (2q11.1; spectrum green)
probe showed three green signals in 8.2% (4/49 cells) and two
green signals in 91.8% (45/49 cells) of urinary cells (Fig. 5).
The neonate was normal in growth and psychomotor devel-
opment at 6 months of age.
Discussion
The present case provides evidence for the usefulness of
application of interphase FISH on uncultured amniocytes for
rapid confirmation of low-level trisomy 2 mosaicism at
amniocentesis. The present case also provides evidence that
the abnormal cell line of trisomy 2 in cases with mosaic
trisomy 2 may disappear after long-term cell cultures. Trisomy
2 mosaicism at amniocentesis has been associated with
pseudomosaicism [23] and also with a discrepancy between
molecular cytogenetic analyses of uncultured amniocytes and
karyotyping of cultured amniocytes [18]. The present case had
trisomy 2 in both the metaphase cells of a single colony.
According to modified guidelines for the management of cases
with suspected amniocyte mosaicism, autosomal trisomy
involving a chromosome 2, 5, 8, 9, 12, 13, 14, 15, 16, 18, 20,
21, or 22 in a single colony (single dish) or in multiple
colonies (single dish) in an in situ culture method is an indi-
cation for extensive workup requiring the examination of 24
colonies from two further separate cultures [24]. The Asso-
ciation for Clinical Cytogenetics [25] has suggested that
particular care should be taken in interpreting level II mosai-
cism (2 or more cells with the same abnormality in a suspicion
culture from a single flask, or in a single abnormal colony
from an in situ culture) for a clinically significant aneuploidy,
and interphase FISH may be used for the investigation of
mosaicism in a prenatal setting. The present case shows that
interphase FISH on uncultured amniocytes in repeated
amniocentesis is very practical for differential diagnosis of
true mosaicism from pseudomosaicism under such a circum-
stance. We suggest that interphase FISH is the molecular
cytogenetic method of choice for rapid confirmation of low-
level mosaicism at amniocentesis. In the present case, the
first amniocentesis revealed 4.5% (1/22 colonies) mosaicism
for trisomy 2 in cultured amniocytes, the second amniocen-
tesis revealed a normal 46,XY karyotype in all 20 colonies of
cultured amniocytes, and the third amniocentesis revealed
a normal 46,XY karyotype in all 30 colonies of cultured
amniocytes. However, at the second amniocentesis, the
Table 1
Reported cases of mosaic trisomy 2 detected by amniocentesis.
Authors Cases Indication Amniocentesis studies Confirmatory studies Outcome and phenotype
Bui et al [8] 47,XY,þ2/46,XY
47,XY,þ2/46,XY
NA
NA
NA
NA
NA
NA
TOP, transverse hemimelia
TOP, ambiguous external genitalia
Casey et al [9] 47,XY,þ2/46,XY Abnormal ultrasound:
ventriculomegaly, discordance
of limbs with body size
Amniocentesis:
T2 ¼ 11.8% (17 colonies)
Cord blood: T2 ¼ 0%
Peripheral blood: T2 ¼ 0%
Cord: T2 ¼ 0%
Placenta: T2 ¼ 0%
Foreskin: T2 ¼ one cell
Delivery at 39 wk, 2445 g,
small for gestational age, high
arched palate, low-set ears,
simian creases, overlapping
fingers, widely spaced nipples
Golabi et al [10]
Sago et al [7]
47,XY,þ2/46,XY Elevated MSAFP Amniocentesis:
T2 ¼ 22.6% (31 colonies)
Blood: T2 ¼ 0% (100 cells)
Skin: T2 ¼ 0% (100 cells)
Ascites: T2 ¼ 0% (100 cells)
Intestine: T2 ¼ 0% (39 cells)
Liver: T2 ¼ 4% (100 cells)
Skin: UPD2 excluded
Ultrasound at 26 wk: IUGR,
DORV, ASD, VSD, hydronephrosis.
Delivery at 30 wk, 1135 g, small
for gestational age, prominent
occiput, beaked and prominent
nose, flat malar area, thin lip,
pointed chin, pectus excavatum,
inguinal hernias, V-shaped palate,
rocker-bottom feet, congenital
heart defects, hydronephrosis,
vesicoureteral reflux, delay
myelination, a thin corpus
callosum, hippocampal dysplasia,
portal fibrosis. At age 16 mo:
hypotonia, microcephaly,
growth retardation,
developmental delay
Harrison et al [11] 47,XY,þ2/46,XY Abnormal maternal
serum screen: elevated
MShCG, Down risk ¼ 1/145
Amniocentesis:
T2 ¼ 32.5% (40 cells)
Cord blood: T2 ¼ 0% (100 cells)
Amnion: T2 ¼ 32%
Chorion: T2 ¼ 20%
Villi: T2 ¼ 12%
Maternal UPD2
Ultrasound at 28e34 wk: IUGR,
oligohydramnios. Delivery at 36 wk,
1710 g, bronchopulmonary
dysplasia. At age 31 mo: growth
delay, normal development, no
neuromuscular delay
Pappas et al [12] Case 2
47,XY,þ2/46,XY AMA
Abnormal ultrasound:
lumbosacral spina bifida,
ventriculomegaly
Elevated AFAFP
Amniocentesis:
T2 ¼ 23.4% (64 cells)
Skin: T2 ¼ 0%
Muscle: T2 ¼ 0%
Placenta: T2 ¼ 30% (20 cells)
Amnion: T2 ¼ 15% (20 cells)
TOP, lumbosacral spina bifida
Webb et al [13] 47,XX,þ2/46,XX AMA
Trisomy 2 at CVS
Amniocentesis:
culture A:
T2 ¼ 23.3% (30 cells)
culture B:
T2 ¼ 0% (30 cells)
Cordocentesis: T2 ¼ 0% (100 cells)
Blood: T2 ¼ 0% (100 cells)
Placenta: T2 ¼ 100% (120 cells)
Skin: T2 ¼ 0% (100 cells)
Maternal UPD2
Oligohydramnios on prenatal
ultrasound. Delivery
at 31 wk, 765 g, patent ductus
arteriosus, congenital pyloric
stenosis, sliding hiatus hernia,
vesicoureteral reflux.
At age 8 mo: normal development,
no obvious dysmorphic features
Hsu et al [14] Case II-1
47,XY,þ2/46,XY AMA Amniocentesis:
T2 ¼ 4% (52 cells)
Blood: T2 ¼ 0% (79 cells)
Placenta: T2 ¼ 0% (52 cells)
Normal liveborn
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Table 1 (continued)
Authors Cases Indication Amniocentesis studies Confirmatory studies Outcome and phenotype
Case II-5
47,XX,þ2/46,XX Elevated MSAFP Amniocentesis:
T2 ¼ 6.3% (32 colonies)
Placenta: T2 ¼ 25% (20 cells) Stillbirth at 21 wk of gestation,
no visible birth defects
Case II-6
47,XX,þ2/46,XX NA Amniocentesis:
T2 ¼ 6.7% (30 colonies)
Placenta: T2 ¼ 25% (20 cells) IUFD
Case II-10
47,XX,þ2/46,XX Elevated MSAFP Amniocentesis:
T2 ¼ 33.3% (30 cells)
Lung: T2 ¼ 13.3% (30 cells)
Placenta: T2 ¼ 20% (30 cells)
Skin: T2 ¼ 0% (50 cells)
Skin: T2 ¼ 0% (50 cells)
TOP, abnormal abortus,
dolichocephaly, oligohydramnios
Case II-11
47,XX,þ2/46,XX NA Amniocentesis:
T2 ¼ 20% (40 cells)
NA Stillbirth
Robinson et al [15] 47,XY,þ2/46,XY Abnormal maternal serum
screen for AFP and hCG,
Down risk ¼ 1/90
Amniocentesis:
culture A:
T2 ¼ 36.7% (30 cells)
culture B:
T2 ¼ 50% (30 cells)
culture C:
T2 ¼ 83.3% (30 cells)
Skin (right): T2 ¼ 4% (100 cells)
Kidney (right): T2 ¼ 3.9% (77 cells)
Adrenal (right): T2 ¼ 7% (100 cells)
Brain: T2 ¼ 0% (35 cells)
Heart: T2 ¼ 3.9% (77 cells)
Testis: T2 ¼ 4% (100 cells)
Cord blood: T2 ¼ 0% (100 cells)
Cord: T2 ¼ 1% (100 cells)
Placenta (site 1): T2 ¼ 73.3% (30 cells)
TOP, mild dysmorphic features,
absent gall bladder, cystic
left kidney, a 13th left rib,
mild unilateral talipes
Roberts et al [16] 47,XY,þ2/46,XY Elevated MSAFP and MShCG
Abnormal prenatal ultrasound:
IUGR, increased bowel
echogenicity
Trisomy 2 at CVS
Amniocentesis:
T2 ¼ 9% (89 cells)
UPD2 excluded
Blood: T2 ¼ 0% (60 cells)
Placenta: T2 ¼ 100% (115 cells)
Cord: T2 ¼ 23% (13 cells)
Severe IUGR, oligohydramnios
on prenatal ultrasound.
Delivery at 26 wk, 440 g,
phenotypically normal liveborn,
neonatal death due to prematurity
Sifakis et al [17] 47,XY,þ2/46,XY AMA Amniocentesis:
T2 ¼ 16% (25 cells)
NA TOP, a male fetus without
external or internal organ
malformation at autopsy
Sifakis et al [6] Mosaic T2 Trisomy 2 at CVS Amniocentesis:
T2 ¼ 1.9% (53 cells)
NA At 12 wk of gestation: fetal
crown-rump length: 50th centile,
NT ¼ 1.0 mm, MS free
b-hCG ¼ 0.55 MoM,
MS PAPP-A ¼ 0.04 MoM.
At 18 wk of gestation: IUGR,
oligohydramnios, absent
end-diastolic flow, coarctation
of the aorta, TOP
Chen et al [18] 47,XX,þ2/46,XX AMA, abnormal
prenatal ultrasound: IUGR
Amniocentesis (1st):
Cultured amniocytes:
T2 ¼ 0% (25 colonies)
Amniocentesis (2nd):
Uncultured amniocytes:
aCGH: mosaic T2
Interphase FISH:
T2 ¼ 12% (50 cells)
Cultured amniocytes:
T2 ¼ 0% (19 colonies)
Amnion: T2 ¼ 7.5% (50 cells)
Cord: T2 ¼ 0% (60 cells)
Blood: T2 ¼ 0% (100 cells)
Placenta: complete T2 (aCGH)
Skin: disomy 2 (aCGH, QF-PCR),
UPD2 excluded
Severe IUGR, oligohydramnios
on prenatal ultrasound. Delivery
at 26 wk, 488 g, small for age,
low-set ears, macroglossia,
clenched hands, neonatal death
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607C.-P. Chen et al. / Taiwanese Journal of Obstetrics & Gynecology 51 (2012) 603e611interphase FISH on uncultured amniocytes revealed 23.4%
(11/47 cells) mosaicism for trisomy 2, but QF-PCR and aCGH
failed to detect trisomy 2 mosaicism on uncultured amnio-
cytes. This is because QF-PCR and aCGH have limitations in
detecting low-level mosaicism trisomy [26,27]. At the third
amniocentesis, the interphase FISH on uncultured amniocytes
revealed 9.4% (5/53 cells) mosaicism for trisomy 2. The cord
blood revealed a normal 46,XY karyotype in all 40 cultured
lymphocytes. By use of interphase FISH analysis, the urinary
cells was found to have 8.2% (4/49 cells) mosaicism for
trisomy 2.
To date, at least 18 cases of mosaic trisomy 2 detected by
amniocentesis have been reported (Table 1). Of these, at least
nine cases (50%) [6e8,10,12e15,18] were associated with
prominent phenotypic abnormalities, suggesting that the
malformation risk should be concerned in prenatal diagnosis
of mosaic trisomy 2 by amniocentesis. Table 1 shows that the
male:female sex ratio for fetal mosaic trisomy 2 is 1.8 (11
males/6 females), indicating a male preponderance in fetal
mosaic trisomy 2 and a natural selection against female
mosaic trisomy 2 conceptuses. Table 1 also shows that mosaic
trisomy 2 can prenatally be associated with elevated maternal
serum AFP (MSAFP), abnormal maternal serum screening,
and abnormal ultrasound findings. Golabi et al [10] and Sago
et al [7] reported an elevated MSAFP level of 2.93 MoM in
a pregnancy with mosaic trisomy 2, congenital heart defects,
IUGR, and hydronephrosis. Pappas et al [12] reported an
elevated amniotic fluid AFP level of 13 standard deviations
above the mean with positive acetylcholinesterase in a preg-
nancy with mosaic trisomy 2, lumbosacral spina bifida, and
ventriculomegaly. Hsu et al [14] reported a pregnancy with an
elevated MSAFP level of 4 MoM, fetal mosaic trisomy 2,
dolichocephaly, and oligohydramnios, and another case with
elevated MSAFP, fetal mosaic trisomy 2, and stillbirth. Har-
rison et al [11] reported an elevated maternal serum human
chorionic gonadotrophin (MShCG) level of 3.67 MoM, indi-
cating a 1:145 risk of Down syndrome in a pregnancy with
mosaic trisomy 2 and maternal UPD 2. Robinson et al [15]
reported a raised Down syndrome risk of 1:90 on maternal
serum screening for AFP and hCG in a pregnancy with mosaic
trisomy 2 and multiple anomalies. Roberts et al [16] reported
an elevated MSAFP level of 3.67 MoM and an elevated
MShCG level of 3.9 MoM in a pregnancy with mosaic trisomy
2, IUGR, and oligohydramnios. The present case was associ-
ated with abnormal maternal serum screening for AFP, uE3,
total b-hCG, and inhibin-A, and a 1:145 risk of Down
syndrome. Table 1 additionally shows that the reported
abnormal ultrasound findings associated with mosaic trisomy
2 at amniocentesis include IUGR, oligohydramnios, congen-
ital heart defects, ventriculomegaly, spina bifida, and
hydronephrosis.
Mosaic trisomy 2 detected postnatally has been described
in four cases [19e22], and there exists phenotypic and cyto-
genetic variability. Cramer et al [19] first reported a 6-month-
old girl with 40% trisomy 2 mosaicism in skin fibroblasts and
a normal 46,XX karyotype in 100 lymphocytes. The girl
manifested IUGR, gross motor and growth delay, scoliosis,
Fig. 1. A karyotype of 47,XY,þ2.
608 C.-P. Chen et al. / Taiwanese Journal of Obstetrics & Gynecology 51 (2012) 603e611unilateral radioulnar hypoplasia, craniosynostosis, broad
halluces, radial deviation of the wrist, frontal bossing, unilat-
eral proptosis, and contralateral ptosis. Gupta et al [20] re-
ported a 3-month-old girl with mosaic trisomy 2, normal
perinatal findings, normal development, and normal growth.
The girl manifested hypomelanosis of Ito. Her blood karyo-
type was normal, but the skin biopsy and cell culture in skin
fibroblasts over the area of pigmentation showed a karyotype
of 47,XX,þ2[9]/46,XX[11]. Mihci et al [21] reported a girl
aged 2.5 years with multiple congenital anomalies, 3% (3/100Fig. 2. Interphase FISH analysis of uncultured amniocytes using the BAC probe
(A) two green signals in an amniocyte with disomy 2 and (B) three green signa
FISH ¼ fluorescence in situ hybridization.cells) trisomy 2 mosaicism in skin fibroblasts, and a normal
46,XX karyotype in peripheral blood. The girl was found to
have large kidneys and diaphragmatic hernia on prenatal
ultrasound. She had a history of diaphragmatic hernia,
duodenal atresia, intestinal malrotation, microcephaly, atrial
and ventricular septal defects, developmental delay, hypotonia,
and seizures. She manifested microbrachycephaly, a receded
frontal hair line, a dysmorphic face with small and wide-set
eyes, epicanthic folds, midface hypoplasia, thin upper lip,
small mouth, down-turned corners of the mouth, a prominentRP11-468G5 (2q11.1) (spectrum green) at the second amniocentesis shows
ls in an amniocyte with trisomy 2. BAC ¼ bacterial artificial chromosome;
Father
Mother
Uncultured
amniocytes
146
D2S1788
(2p22.3)
150
154
154146
D2S1394
(2p13.2)
169
149
173
185
185173
150
Fig. 3. Representative electrophoretograms of quantitative fluorescent poly-
merase chain reaction assays. The markers D2S1788 and D2S1394 show two
peaks of equal fluorescent activity from two different parental alleles in
uncultured amniocytes with a dosage ratio of 1:1 (paternal allele:maternal
allele).
609C.-P. Chen et al. / Taiwanese Journal of Obstetrics & Gynecology 51 (2012) 603e611mandible, and hypopigmented spots on the skin of the anterior
abdominal wall. Prontera et al [22] reported a 7-year-old boy
with multiple malformations, intellectual disabilities, 25%
trisomy 2 mosaicism in skin fibroblasts, and a normal 46,XY
karyotype in peripheral blood. Severe oligohydramnios was
noted prenatally. The boy postnatally manifested smallness for
age, bilateral deafness, psychomotor retardation, micro-
cephaly, microanophthalmia, cleft palate, high forehead, full
cheeks, microstomia, abnormal ears, smooth philtrum,
grooved chin, short neck, torticollis, valgus club foot,Fig. 4. Interphase FISH analysis of uncultured amniocytes using the BAC probe RP
green signals in an amniocyte with disomy 2 and (B) three green signals in
FISH ¼ fluorescence in situ hybridization.camptodactyly, clinodactyly, hallux valgus, overriding toes,
bilateral cryptorchidism, small penis, face and body asym-
metry, caudal dysgenesis, lack of sacrum and part of coccyx,
and Hirschsprung disease.
Complete trisomy 2 detected postnatally has always been
associated with congenital anomalies [21,28e30]. Chaliha
et al [28] reported a 34-gestational-week acardiac twin with
a karyotype of 47,XY,þ2 in the skin. Blaicher et al [29]
reported a term acardiac twin with a karyotype of 47,XX,þ2
in the skin. Seller et al [30] reported a 13-gestational-week
fetus with microcephaly, iniencephaly, encephalocele, thoracic
spina bifida, a karyotype of 47,XY,þ2 in the umbilical cord,
and trisomy 2 in the skin by interphase FISH. Mihci et al [21]
reported a term acardiac twin with a karyotype of 47,XX,þ2
in the skin.
Mosaic trisomy 2 at amniocentesis can be associated with
mosaic trisomy 2 or complete trisomy 2 in the placenta
(Table 1). High-level trisomy 2 mosaicism and complete
trisomy 2 in the placenta with or without fetal UPD 2 have
been well known to be associated with IUGR, oligohy-
dramnios, and adverse fetal outcome [6,13,15,18,31e36].
The presence of trisomy 2 in amnion has additionally been
found to correlate with poor pregnancy outcome even when
the fetus has a normal karyotype [36]. Mosaic trisomy 2 at
amniocentesis has always been associated with a normal
karyotype in the blood. Therefore, cord blood sampling for
rapid confirmation of mosaic trisomy 2 at amniocentesis is
not practical.
In summary, we present prenatal diagnosis and molecular
cytogenetic analysis of mosaic trisomy 2 using uncultured and
cultured amniocytes in a pregnancy with favorable fetal
outcome. We demonstrate the usefulness of interphase FISH
on uncultured amniocytes for rapid confirmation of low-level
trisomy 2 mosaicism at amniocentesis and provide evidence
that the abnormal cell line of trisomy 2 may disappear after
long-term amniocyte cultures.11-468G5 (2q11.1) (spectrum green) at the third amniocentesis shows (A) two
an amniocyte with trisomy 2. BAC ¼ bacterial artificial chromosome;
Fig. 5. Interphase FISH analysis of uncultured urinary cells using the BAC probe RP11-468G5 (2q11.1) (spectrum green) after birth shows (A) two green signals in
a urinary cell with disomy 2 and (B) three green signals in a urinary cell with trisomy 2. BAC ¼ bacterial artificial chromosome; FISH ¼ fluorescence in situ
hybridization.
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